The STADA Group
At STADA, we follow our purpose of “Caring for People’s Health as a Trusted Partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we have been perceived as a reliable and trustworthy partner for 130 years. Our products help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. We offer our employees an attractive working environment in which they can develop personally.
STADA focuses on a three-pillar strategy consisting of consumer healthcare products, generics, specialty pharmaceuticals. Worldwide, STADA Arzneimittel AG sells its products in over 100 countries. consumer healthcare brands such as Nizoral®, Zoflora®, Grippostad®, SNUP®, Silomat® and Hirudoid® are among the top sellers in their respective product categories. In financial year 2024, STADA achieved group sales of EUR 4,059 million and adjusted constant-currency earnings before interest, taxes, depreciation and amortization (adj. cc EBITDA) of EUR 886 million. As of 31 December 2024, STADA employed 11,649 people worldwide.
Leading STADA Brands
Media Relations
In addition to the latest news you can find here information on areas such as personnel, corporate social media, STADA Group Health Report and more.
